SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-22-002025
Filing Date
2022-06-17
Accepted
2022-06-17 17:00:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13da113398002_06152022.htm SC 13D/A 38086
  Complete submission text file 0000921895-22-002025.txt   39481
Mailing Address 1201 NORTH MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address
Javitt Jonathan C (Filed by) CIK: 0001303782 (see all company filings)

Type: SC 13D/A

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Subject) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90195 | Film No.: 221024782
SIC: 2834 Pharmaceutical Preparations